// App-Quantinova.ai

BSH2020‐PO‐183 : A feasibility study on the provision of extended matched red cells for transfusion support in chronic haematological diseases

Researchers

Presenter

  • S. Henton

Principal Investigators

  • M. Murphy

  • J. Staves

Medical Centers

  • Blood Transfusion, Oxford University Hospital, Headington, Oxford, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelodysplastic Syndrome

  • Myelofibrosis

  • Chronic myelomonocytic leukemia

Biomarkers

  • Dopamine transporter

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

  • Red Blood Cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved